
“Uncovering the Truth: Ongoing Investigation of Pliant Therapeutics Inc. – Contact Levi and Ko for Updates”
Levi & Korsinsky Investigates Pliant Therapeutics, Inc. for Possible Securities Violations What Happened? On February 7, 2025, Pliant Therapeutics, Inc. announced that it had voluntarily paused enrollment and dosing in the BEACON-IPF Phase 2b trial of bexotegrast for patients with idiopathic pulmonary fibrosis. This decision came after a data review and recommendations by the trial’s…